Palisade Bio Inc (PALI) — Strategic Asset Allocation Index
Palisade Bio Inc (PALI) has a Strategic Asset Allocation Index of 1.7% as of June 2023. Strategic assets (PP&E of $261.00K plus long-term investments of $-) total $261.00K, measured against net assets of $15.80 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see PALI market cap overview.
SAAI
Strategic Assets
PP&E
Net Assets
Palisade Bio Inc Strategic Asset Allocation Index (2016–2021)
This chart shows how Palisade Bio Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2021. As of June 2023, the index stands at 1.7%, representing strategic assets of $261.00K against net assets of $15.80 Million USD. See PALI net asset quality index to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Palisade Bio Inc (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Palisade Bio Inc from 2016 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore net asset growth rate of Palisade Bio Inc to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 1.5% | $112.00K | $112.00K | $- | $7.37 Million | ▼ -6.7 pp |
| 2019 | 8.2% | $420.00K | $420.00K | $- | $5.13 Million | ▲ +8.1 pp |
| 2018 | 0.1% | $5.00K | $5.00K | $- | $6.05 Million | ▼ -1.9 pp |
| 2017 | 2.0% | $172.89K | $172.89K | $- | $8.52 Million | ▼ -0.3 pp |
| 2016 | 2.4% | $269.56K | $269.56K | $- | $11.33 Million | — |